%0 Journal Article
%A Du, Yijia
%A Chu, Qian
%A Lou, Yanyan
%A He, Yong
%A Hu, Hongbo
%A Hu, Qipeng
%A Huang, Meijuan
%T Editorial: Immunotherapy for NSCLC with oncogenic driver variants.
%J Frontiers in oncology
%V 12
%@ 2234-943X
%C Lausanne
%I Frontiers Media
%M DKFZ-2022-03208
%P 1095947
%D 2022
%K immune checkpoint inhibitors (Other)
%K lung cancer (Other)
%K oncogenic driver variants (Other)
%K targeted therapy resistance (Other)
%K tumor immune microenvironment (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:36568249
%2 pmc:PMC9775290
%R 10.3389/fonc.2022.1095947
%U https://inrepo02.dkfz.de/record/186487